Sp1298
FROM EPIDEMIOLOGY TO ENDPOINTS: EVOLVING PERSPECTIVES ON EOSINOPHILIC ESOPHAGITIS (EOE) MEDICAL SYMPOSIUM
Date
May 21, 2024
Presenters
University of North Carolina School of Medicine
Northwestern University - The Feinberg School of Medicine
Tracks
Related Products
PANEL DISCUSSION
The field of EoE is undergone remarkable and dramatic changes in the last decade. With the advent of biologics, a better understanding of all current treatment options and how to pick the right option for a given patient is needed…
CASED BASED DISCUSSION
SOCIETY: AGA
EOSINOPHILIC ESOPHAGITIS: CLINICAL IMPLICATIONS OF DISEASE PROGRESSION
EoE is a chronic, type 2 inflammatory esophageal disease associated with dysphagia, regurgitation, and food impaction. Diagnostic delays result in disease progression, including stricture formation…
EPIDEMIOLOGIC BURDEN AND PROJECTIONS FOR EOSINOPHILIC ESOPHAGITIS-ASSOCIATED EMERGENCY DEPARTMENT VISITS IN THE UNITED STATES (2009-2030)
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
